UK7-18749-65506
4 vaccinations
1 coded response
52 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 805 / CO
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-19
Dose 1 — Pfizer-BioNTech
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-25
- 2020-12-26
- 2021-01-02
-
2021-01-09
Dose 2 — Pfizer-BioNTech
- 2021-01-09
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-01-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-12
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-23
- 2021-02-01
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-04-10
- 2021-07-10
-
2021-09-27
Dose 3 — Pfizer-BioNTech
-
2021-09-28
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-11
- 2021-10-19
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-12-27
- 2022-03-28
-
2022-09-15
Dose 4 — Pfizer-BioNTech
- 2022-09-15
-
2022-09-16
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend schoolAdult check-in
-
2022-09-17
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-09-18
- 2022-09-19
- 2022-09-20
- 2022-09-21
- 2022-09-22
- 2022-09-29
- 2022-10-06
- 2022-10-13
- 2022-10-20
- 2022-10-27
-
2022-12-15
Survey response — 3 months, dose 4MedDRA: Abdominal discomfort, Fatigue — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Digestive distress and fatigueMedDRA releases: 2024-11 · check-in free text available
- 2023-03-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
| 4 | 2022-09-15 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 priority 2/3 (triaged and no follow up)
Free text
Release 12 — 3 months, dose 4
Symptoms: Digestive distress and fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal discomfort | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release